Epistaxis - A Common Clinical Condition
Epistaxis, also known as nosebleed, occurs due to rupturing of a small blood vessel in the lining of nose, as the interior of the nose is highly delicate and sensitive and could not tolerate certain factors that make them fragile and prone to burst resulting in bleeding. Nosebleeds are common mostly during winter, as more of the upper respiratory infections occur during this season.
In most cases, epistaxis responds effectively to nasal cauterization or nasal packaging or both the treatments. People experiencing recurrent bouts of nosebleeds are usually recommended to undergo surgical options or embolization procedures that are available in the hospitals and ENT clinics. The most common treatment employed on the epistaxis patients is either chemical or electrical cautery. The method is easy to perform, cheap, and does not involve any serious risk. Cauterization refers to a procedure in which a small tissue at the bleeding site is removed or burnt with the help of chemicals such as silver nitrate or mild electric shocks. There are a number of topical applications such as tranexamic acid that is also available in the market that helps to curtail nosebleeds. According to a research article published in International Journal of Otolaryngology in 2015, epistaxis is estimated to affect around 10-12% of the total population of which around 80% patients require medical attention as majority of epistaxis cases are not self-limiting and cannot be resolved due to intervention. Increasing number of cases in nosebleeds are thus expected to foster the growth of global epistaxis market.
The global epistaxis market was valued at US$ 130.0 million in 2016 and is expected to witness a CAGR of 5.7% during the forecast period (2017 – 2025).
Figure 1. Global Epistaxis Market Share, By Product Type (%)
Increasing prevalence of hypertension and change in environment are expected to drive the growth of global epistaxis market
Rising cases of cardiovascular disorders, mainly hypertensive diseases, which are highly susceptible to hemorrhage are the leading causes of epistaxis. According to the Medical Statistics of World Health Organization in 2015, there were approximately 289,000 cases of hypertension recorded among pregnant women. According to the American Pregnancy Organization, the circulatory system expands during pregnancy so as to accommodate the baby. The expansion leads to increase in creation and circulation of blood that may lead to problematic issues and frequent nosebleeds during pregnancy. Thus, the rising number of pregnant women suffering from hypertensive diseases is expected to boost the global epistaxis market. Additionally, rising awareness among public regarding the benefits of medical assistance for frequent bouts of bleeding also support the growth of global epistaxis market. Alongside, rise in the geriatric population, as well as rapid technological development in the healthcare sector, add up to the market growth. However, side effects of cauterization procedures such as chemical allergies and pain, swelling, bruises, and running nose may hinder the market growth.
Key players are involved in research and development for technological advancements and innovation of epistaxis products. For instance, in 2016, Smith & Nephew launched a range of epistaxis devices with RAPID RHINO technology that has a blend of carboxymethylcellulose (CMC) within them exhibiting self-lubricating properties that provide gentle and even compression to the nasal area and helps in the quicker re-conformation of the nasal anatomy. Various similar technological advancements and strategic implementations by emerging and established market players are expected to foster the global epistaxis market growth.
Epistaxis, also referred as nose bleeding, is a common clinical condition that results in loss of blood from the tissue lining of the nose. Epistaxis is usually classified as anterior or posterior epistaxis. Anterior epistaxis is defined as the bleeding from the anterior septum of the nose that is usually known as Kiesselbach plexus. Anterior epistaxis is also known as acute epistaxis and is the most commonly encountered form that can be cured through various medical treatments. On the other hand, posterior nosebleeds originating from the back of nasal package, near the throat are a relatively less common clinical condition and can prove to be serious as it may result in significantly large amount of blood loss. The posterior nosebleeds lead to massive blood loss and difficulty in breathing that may result in fatigue, paleness, and chest pain. However, most nosebleeds are rarely life threatening and are benign, self-limiting, spontaneous but recurrent. Epistaxis can be caused due to various factors such as lack of humidity in the atmosphere that results in the drying of mucosal tract, hypertension, and nasal tumors and also due to consumption of certain drugs, smoking, and alcohol. According to the World Health Organization, approximately 60% of people across the globe has faced nose bleeding at least once in their lives.
The recent past has witnessed a steady rise in incidence of heart-related disorders leading to hypertension and high blood pressure. Hypertension serves to be one of the major causes of epistaxis and the increase in its prevalence is expected to be one of the major factors responsible to drive the growth of the global epistaxis market. Moreover, increase in number of patients suffering from nasal tumors of benign and malignant types also contributes to the market growth. According to the American Cancer Society, around 2000 new cases related to nasal cavity and paranasal sinuses are registered every year in the U.S. The same article states that the sinuses that are highly responsible for epistaxis are much more prevalent in certain areas of the world that includes South Africa and Japan. On the other hand, the surgical procedures that are used commonly for the treatment of epistaxis, known as cauterization, results in a large number of side effects such as pain, swelling, and running nose. This is expected to hinder the market growth over the forecast period. However, this leads to open up a wide scope for the existing as well as new market players to come up with innovative treatment options with minimum or no side effects to establish a significant position in the market.
The report segments the global epistaxis market on the basis of product type and geography. On the basis of product type, the global epistaxis market is segmented into Vasoconstrictors, Anesthetics, Antibiotic Ointments, and Cauterizing Agents. On the basis of geography, the market is divided into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 90 market data tables and 40 figures on "Epistaxis Market - Global forecast to 2025”.
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.